The Use of Adjunct Oxygen High-Level Laser Therapy on the Clinical and Microbiological Outcomes of Peri-implant Disease
1 other identifier
interventional
16
1 country
1
Brief Summary
The goal of this clinical trial is to learn whether using a special light-activated treatment called photodynamic therapy, or more specifically, its modified version called oxygen high-level laser therapy, using a high-powered diode laser along with 3% hydrogen peroxide, can improve gum health around dental implants. It tests whether adding this to regular cleaning treatments could reduce harmful bacteria and support better healing. The aim is to determine whether a specific protocol is an effective way to treat infections around dental implants. Participants in the study will receive two types of treatment on different dental implants:
- One implant will be treated with the oxygen high-level laser therapy using diode laser and hydrogen peroxide after mechanical cleaning.
- The other implant will receive diode laser therapy without hydrogen peroxide after mechanical cleaning. Researchers will compare how the gums respond to each treatment, looking at signs such as inflammation, and determine whether the number of harmful bacteria has been reduced at three time points.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 5, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 7, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2025
CompletedFirst Submitted
Initial submission to the registry
August 26, 2025
CompletedFirst Posted
Study publicly available on registry
December 17, 2025
CompletedDecember 17, 2025
August 1, 2025
1.4 years
August 26, 2025
December 14, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Probing Pocket Depth
Probing pocket depth (PPD): The distance from the gum margin to the bottom of the pocket around a tooth or implant using a periodontal probe. Measurements were taken using PCPUNC 15 periodontal probe inserted parallel to the long axis of the implant until soft resistance was felt. Six sites per implant were recorded (mesiobuccal, mid-buccal, distobuccal, mesio-oral, mid-oral, disto-oral), and mean values were calculated. Higher values indicate deeper pockets and greater inflammation. Unit of Measure: millimeters (mm)
From enrollment to the end of follow-ups at 3 months.
Bleeding on Probing
Bleeding on Probing (BOP): Percentage of sites exhibiting bleeding upon gentle probing around a tooth or implant using a periodontal probe. Each site was scored as bleeding (yes) or not bleeding (no) within 30 seconds after probing. The percentage of bleeding sites was calculated as: (number of bleeding sites ÷ total sites) × 100. Higher percentages indicate greater inflammatory response. Unit of Measure: Percentage (%)
From enrollment to the end of follow-ups at 3 months
Gingival Index
Gingival index: A clinical measure used to assess the severity of gingival inflammation. It is based on the color, consistency, and bleeding of the gums when gently probed. The scale ranges from 0 to 3, where: 0 = normal gingiva (no inflammation) 1. = mild inflammation (slight color change, no bleeding on probing) 2. = moderate inflammation (redness, edema, bleeding on probing) 3. = severe inflammation (marked redness, ulceration, spontaneous bleeding) Higher scores indicate more severe inflammation. Unit of Measure: Units on a scale (0-3)
From enrollment to the end of follow-ups at 3 months
Plaque Index
Plaque index: A scoring system used to measure the amount of dental plaque on the teeth or implants. The scale ranges from 0 to 3, where: 0 = no plaque detected 1. = plaque only detectable by probe 2. = visible plaque 3. = abundant plaque accumulation Higher scores indicate greater plaque accumulation. Unit of Measure: Units on a scale (0-3)
From enrollment to the end of follow-ups at 3 months
Secondary Outcomes (2)
Bacterial Load of Peri-Implant Pathogens (qPCR)
From enrollment to the end of follow-ups at 3 months.
Suppuration
From enrollment to the end of follow-ups at 3 months
Study Arms (2)
Diode laser and hydrogen peroxide
ACTIVE COMPARATORThe dental implant will receive treatment using diode laser and hydrogen peroxide following mechanical debridement.
Diode laser
ACTIVE COMPARATORThe dental implant will receive treatment using diode laser following mechanical debridement.
Interventions
After mechanical debridement of the affected dental implant, a 3% hydrogen peroxide solution will be applied to the peri-implant pocket. This will be followed by irradiation using a diode laser at 940nm wavelength, applied for 60 seconds per site. The intervention will be performed in a single treatment session.
After mechanical debridement of the affected dental implant, irradiation using a diode laser at 940nm wavelength, applied for 60 seconds per site will be performed. This intervention will be administered in a single treatment session.
Eligibility Criteria
You may qualify if:
- Patients 18 years or older.
- Patients diagnosed with peri-implant disease (peri-implant mucositis or peri-implantitis) according to the 2017 World Workshop criteria in at least two non-adjacent, single-crown, bone-level dental implants.
- Patients that have not undergone periodontal treatment and/or were prescribed antibiotics in the last three months prior to initial visit.
- Patients with a healthy periodontal status
- At least 1 year of functional implants.
- Non-Smokers.
You may not qualify if:
- Immunocompromised patients.
- Pregnancy or breastfeeding.
- Known allergies to any materials used in the study.
- Patients classified as ASA Physical Status ≥ III.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Jordan University of Science and Technology
Irbid, Alabama, 22110, Jordan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Rola Alhabashneh
Jordan University of Science and Technology
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 26, 2025
First Posted
December 17, 2025
Study Start
February 5, 2024
Primary Completion
July 7, 2025
Study Completion
August 1, 2025
Last Updated
December 17, 2025
Record last verified: 2025-08